SlideShare a Scribd company logo
1 of 4
Download to read offline
Stereocontrolled synthesis of quinine and quinidine
Junji Igarashi, Masahiro Katsukawa, Yong-Gang Wang, Hukum P. Acharya
and Yuichi Kobayashi*
Department of Biomolecular Engineering, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan
Received 12 February 2004; revised 10 March 2004; accepted 12 March 2004
Abstract—Disubstituted cyclopentene was prepared from cyclopentene monoacetate and transferred into disubstituted piperidine
via oxidative cleavage of the olefin moiety followed by piperidine ring formation. The piperidine was then condensed at the side
chain with a quinoline part to afford the olefin precursor of quinine. Finally, the olefin was converted into quinine through the
corresponding epoxide. Quinidine was synthesized in a similar way.
Ó 2004 Elsevier Ltd. All rights reserved.
Quinine and quinidine have been used as effective ther-
apeutic agents against malaria for over three centuries,
and, recently, other medicinal applications have been
reported for these alkaloids.1
On the other hand, the
unique structure of these alkaloids has attracted much
attention as chiral catalysts in asymmetric reactions.2
Usually structural modifications, when required, have
been performed at the hydroxyl and/or amino group
sites, providing moderate to high efficiencies in various
reactions. In cases where efficiency is not high, modifi-
cation of the structural backbone would be an alterna-
tive way of attaining higher efficiency. To execute
research work along this line, it is indispensable to
establish a flexible approach to these alkaloids.
N
N
OMe
OH N
N
OMe
OH
quinine (1) quinidine (2)
8
9
3
4
The results of the previous investigation over 50 years
into the synthesis of these alkaloids are suggestive of
achieving successful total synthesis. These works are
briefly described in the first and stereoselective total
synthesis of quinine (1) published by Stork et al. in
2001,3
who prepared the 9-deoxy-quinine 3 in a stereo-
selective way through a 2,4,5-trisubstituted piperidine
(Fig. 1). Previously, Uskokovic and co-workers4
and
Gates et al.5
independently synthesized the deoxy-qui-
nine 3 and converted it into 1 by hydroxylation using O2
and t-BuOK with 5:1 stereoselectivity. This step was
modified by Stork (O2, NaH, DMSO) to afford 1 more
selectively (14:1). However, the synthesis seems hardly
applicable to quinidine synthesis because the method
developed is specialized for production of the key tri-
substituted piperidine. Quite recently, Jacobsen and
co-workers reported synthesis of 1 and 2.6
In his syn-
thesis, the 3,4-disubstituted piperidine, synthesized with
a 3:1 ratio regarding the cis/trans substitutions at C(3)
and C(4), was transformed, after condensation with the
quinoline part, into epoxide 4 (for 1) and the diaste-
reomeric epoxide (for 2), respectively, through the
Sharpless AD reaction, and each epoxide was converted
4
N
N
OMe
3
OMe
NHN
O 4
3
Figure 1. The previous intermediates for synthesis of quinine (1).
Keywords: Quinine; Quinidine; Piperidine; Cyclopentene-1,3-diol
monoacetate; Epoxide ring opening.
* Corresponding author. Tel./fax: +81-45-924-5789; e-mail: ykobayas@
bio.titech.ac.jp
0040-4039/$ - see front matter Ó 2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2004.03.085
Tetrahedron Letters 45 (2004) 3783–3786
Tetrahedron
Letters
into the target alkaloid. These epoxides were originally
synthesized and cyclized to these alkaloids by Uskoko-
vic and co-workers,4
though at that time the synthesis of
the epoxide was nonstereoselective.7
Herein, we report
stereoselective synthesis of a 3,4-disubstituted piperidine
and its conversion into 1 and 2.
We have chosen epoxide 4 as the key intermediate of 1,
and envisioned a synthesis of 4 as illustrated in Scheme 1
from olefin 58
by using steps consisting of the Sharpless
et al. asymmetric dihydroxylation9
and subsequent
epoxide ring formation.10
On the other hand, we selected
piperidine aldehyde 6 and quinoline phosphonate 7 as
the parts of olefin 5. While a number of synthetic
methods of the 3,4-disubstituted piperidines of this type
(the acid is known as meroquinene) have been
reported,11;12
we investigated an alternative route start-
ing with acetate 813
because a variety of carbon nucleo-
philes as substituents on the piperidine ring can be in-
stalled on the cyclopentene ring by using reactions
developed by us14;15
and others.16
The strategy based on
these reactions is a synthetic advantage to execute the
study mentioned above. On the other hand, the previous
syntheses of the substituted piperidines seem to lack
such flexibility.
Synthesis of the piperidine aldehyde 6 through key
cyclopentene 11 and its conversion into quinine (1) are
presented in Scheme 2. Monoacetate 8 (95% ee) was
converted into methyl ester 9. High yield of 98% for
step a was attained by using the conditions recently
developed by us.17
Reduction of the ester and selective
protection of the primary hydroxyl group furnished 10
in 63% yield. Claisen rearrangement with vinyl ether and
Hg(OAc)2 as a catalyst at 190 °C afforded aldehyde,
which upon reduction with NaBH4 and subsequent
1
O
4 +
AcO OH
6
(1R)-isomer
1
5
N
OMe
NBz
OHC
NBz
N
OMe
P(OEt)2
7
8
Scheme 1. Retrosynthesis of quinine (1).
Scheme 2. Synthesis of quinine (1): (a) CH2(CO2Me)2, t-BuOK, Pd(PPh3)4 (cat.); (b) KI, DMF, 125 °C; (c) LiAlH4; (d) TBDPSCl, imidazole; (e)
CH2@CHOEt, Hg(OAc)2 (cat.), 190 °C; (f) NaBH4; (g) t-BuCOCl, Et3N, CH2Cl2; (h) O3, n-PrOH, )78 °C, then NaBH4; (i) I2, PPh3, imidazole; (j)
BnNH2, dioxane; (k) ClCO2 Et, toluene; (l) NaOEt, EtOH; (m) o-(NO2)C6H4SeCN, PBu3, THF then 35% H2O2, THF; (n) MeLi, 0 °C; (o) BzCl; (p)
TBAF; (q) PCC; (r) 7, NaH, THF, rt; (s) AD-mix-b, 0 °C to rt; (t) MeC(OMe)3, PPTS (cat.), CH2Cl2, TMSCl, K2CO3, MeOH; (u) DIBAL-H,
toluene; (v) DMF, 160 °C.
3784 J. Igarashi et al. / Tetrahedron Letters 45 (2004) 3783–3786
protection of the resulting hydroxyl group as the piva-
loyl ester (Piv ¼ t-BuCO) produced the key cyclopen-
tene 11 in good overall yield.
With the necessary substituents for piperidine aldehyde
6 being installed as masked forms, construction of the
piperidine ring was then studied. Ozonolysis of cyclo-
pentene 11 in n-PrOH18
at )78 °C followed by reductive
work-up with NaBH4 afforded alcohol 12, which was
converted into iodide 13 in 72% yield from 11. Nucleo-
philic amino cyclization of 13 with BnNH2 in dioxane at
100 °C produced the N-benzyl piperidine 14 quantita-
tively. The N-protection was changed to the ethoxy-
carbonyl group with ClCO2Et to produce the piperidine
carbamate 15 in good yield. Transformation of 15 with
EtONa in refluxing EtOH furnished the alcohol, which
was converted into olefin 16 by the Grieco et al. pro-
tocol.19
The overall yield of 16 from 13 was 75%. The
N-protective group (CO2Et) of 16 was altered to the
benzoyl group at this stage to produce the benzoyl
amine 17 in 61% yield.20;21
Finally, the TBDPS group
was removed with TBAF, and the resulting alcohol was
oxidized with PCC to the key aldehyde 6 in good yield.
Phosphonate 7 was synthesized from commercially
available 20 (Scheme 3). At the outset, 20 was converted
into quinoline 21 by the literature procedure.22
The
methyl group on the ring was then oxidatively trans-
formed into the hydroxymethyl group according to the
method of Unno et al. and Isobe.23
Remaining conver-
sion was accomplished under the conditions presented in
Scheme 3, furnishing the key quinoline 7 in 50% yield
from alcohol 22.
Condensation of the key piperidine 6 with anion derived
from the quinoline 7 and NaH produced olefin 5 in 82%
yield (Scheme 2). Dihydroxylation of 5 with AD-mix-b
proceeded as usual and the resulting diol 18 was con-
verted into epoxide 1924
in 85% yield (two steps) by
using the protocol developed by Sharpless and
co-workers.10
Finally, the N-benzoyl group was
removed and the resulting 4 underwent cyclization with
the nitrogen atom in hot DMF to furnish quinine (1) in
66% yield from 19. Quinine thus synthesized was iden-
tical with that obtained from Sigma by 1
H NMR spec-
troscopy and TLC analysis.
In a similar manner, olefin 5 was converted into the
corresponding diol 24 with AD-mix-a, and the same
transformation as described above furnished quinidine
(2) in good yield (Scheme 4).
Acknowledgements
This work was supported by a Grant-in-Aid for Scien-
tific Research from the Ministry of Education, Science,
Sports, and Culture, Japan.
References and notes
1. (a) White, N. J.; Looareesuwan, S.; Warrell, D. A.;
Warrell, M. J.; Bunnag, D.; Harinasuta, T. Am. J. Med.
1982, 73, 564–572; (b) List, A. F. Leukemia 1996, 10, 937–
942; (c) Wilairatana, P.; Krudsood, S.; Treeprasertsuk, S.;
Chalermrut, K.; Looareesuwan, S. Arch. Med. Res. 2002,
33, 416–421.
2. Recent and selected reports: (a) Wynberg, H.; Staring, E.
G. J. J. Am. Chem. Soc. 1982, 104, 166–168; (b) Jacobsen,
E. N.; Marko, I.; Mungall, W. S.; Schroeder, G.;
Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 1968–
1970; (c) Amberg, W.; Bennani, Y. L.; Chadha, R. K.;
Crispino, G. A.; Davis, W. D.; Hartung, J.; Jeong, K.-S.;
Ogino, Y.; Shibata, T.; Sharpless, K. B. J. Org. Chem.
1993, 58, 844–849; (d) Becker, H.; Sharpless, K. B. Angew.
Chem., Int. Ed. Engl. 1996, 35, 448–451; (e) Li, G.; Angert,
H. H.; Sharpless, K. B. Angew. Chem., Int. Ed. Engl. 1996,
35, 2813–2817; (f) Lygo, B.; Wainwright, P. G. Tetrahe-
dron Lett. 1997, 38, 8595–8598; (g) Lygo, B.; Wainwright,
P. G. Tetrahedron Lett. 1998, 39, 1599–1602; (h) Iwabuchi,
Y.; Nakatani, M.; Yokoyama, N.; Hatakeyama, S. J. Am.
Chem. Soc. 1999, 121, 10219–10220; (i) Blake, A. J.;
Friend, C. L.; Outram, R. J.; Simpkins, N. S.; Whitehead,
A. J. Tetrahedron Lett. 2001, 42, 2877–2881; (j) Jew, S.-s.;
Yoo, M.-S.; Jeong, B.-S.; Park, Y., II; Park, H.-g. Org.
Lett. 2002, 4, 4245–4248; (k) Lambers, M.; Beijer, F. H.;
Padron, J. M.; Toth, I.; deVries, J. G. J. Org. Chem. 2002,
67, 5022–5024; (l) Rogers, L. M.-A.; Rouden, J.; Lecomte,
L.; Lasne, M.-C. Tetrahedron Lett. 2003, 44, 3047–3050;
(m) Jew, S.-s.; Jeong, B.-S.; Lee, J.-H.; Yoo, M.-S.; Lee,
Scheme 3. Synthesis of quinoline phosphonate 7: (a) H2SO4; (b)
POCl3; (c) Zn, AcOH; (d) m-CPBA, CH2Cl2, rt; (e) Ac2O, rt; (f)
K2CO3, MeOH; (g) SOCl2, CH2Cl2, reflux; (h) H–P(@O)(OEt)2,
n-BuLi, THF.
5
N
OMe
NBz
OH
OH
2
a b
87%
N
OMe
NBz
c,d
88%
O
55%
24
25
Scheme 4. Synthesis of quinidine (2): (a) AD-mix-a, 0 °C to rt; (b)
MeC(OMe)3, PPTS (cat.), CH2Cl2, TMSCl, K2CO3, MeOH; (c) DI-
BAL-H, toluene; (d) DMF, 160 °C.
J. Igarashi et al. / Tetrahedron Letters 45 (2004) 3783–3786 3785
Y.-J.; Park, B.-s.; Kim, M. G.; Park, H.-g. J. Org. Chem.
2003, 68, 4514–4516, and references cited therein.
3. Stork, G.; Niu, D.; Fujimoto, R. A.; Koft, E. R.;
Balkovec, J. M.; Tata, J. R.; Dake, G. R. J. Am. Chem.
Soc. 2001, 123, 3239–3242.
4. (a) Gutzwiller, J.; Uskokovic, M. J. Am. Chem. Soc. 1970,
92, 204–205; (b) Gutzwiller, J.; Uskokovic, M. R. J. Am.
Chem. Soc. 1978, 100, 576–581.
5. Gates, M.; Sugavanam, B.; Schreiber, W. L. J. Am. Chem.
Soc. 1970, 92, 205–207.
6. Raheem, I. T.; Goodman, S. N.; Jacobsen, E. N. J. Am.
Chem. Soc. 2004, 126, 706–707.
7. Similar quinuclidine formations from epoxides have been
reported: (a) Grethe, G.; Gutzwiller, J.; Lee, H. L.;
Uskokovic, M. R. Helv. Chim. Acta 1972, 55, 1044–1047;
(b) Gutzwiller, J.; Uskokovic, M. R. Helv. Chim. Acta
1973, 56, 1494–1503; (c) Taylor, E. C.; Martin, S. F.
J. Am. Chem. Soc. 1972, 94, 6218–6220; (d) Lygo, B.;
Crosby, J.; Lowdon, T.; Wainwright, P. G. Tetrahedron
1999, 55, 2795–2810.
8. Olefin 5 has been reported to afford a mixture of
9-deoxy-quinine 3 and the C(8)-epimer in 1:1 ratio: (a)
see Refs. 4a,5,7c; (b) Taylor, E. C.; Martin, S. F. J. Am.
Chem. Soc. 1974, 96, 8095–8102.
9. (a) Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino,
G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.; Morikawa,
K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992,
57, 2768–2771; (b) Kolb, H. C.; VanNieuwenhze, M. S.;
Sharpless, K. B. Chem. Rev. 1994, 94, 2483–2547.
10. Kolb, H.; Sharpless, K. B. Tetrahedron 1992, 48, 10515–
10530.
11. (a) Brown, R. T.; Leonard, J. J. Chem. Soc., Chem.
Commun. 1978, 725–726; (b) Hanessian, S.; Faucher,
A.-M.; Leger, S. Tetrahedron 1990, 46, 231–243; (c)
Danieli, B.; Lesma, G.; Mauro, M.; Palmisano, G.;
Passarella, D. Tetrahedron: Asymmetry 1990, 1, 793–800;
(d) Barco, A.; Benetti, S.; De Risi, C.; Pollini, G. P.;
Romagnoli, R.; Spalluto, G.; Zanirato, V. Tetrahedron
1994, 50, 2583–2590.
12. (a) Woodward, R. B.; Doering, W. E. J. Am. Chem. Soc.
1945, 67, 860–874; (b) Uskokovic, M.; Reese, C.; Lee, H.
L.; Grethe, G.; Gutzwiller, J. J. Am. Chem. Soc. 1971, 93,
5902–5904; (c) Uskokovic, M.; Gutzwiller, J.; Henderson,
T. J. Am. Chem. Soc. 1970, 92, 203–204; (d) Grethe, G.;
Lee, H. L.; Mitt, T.; Uskokovic, M. R. Helv. Chim. Acta
1973, 56, 1485–1494; (e) Augustine, R.; Koletar, G. Synth.
Commun. 1974, 4, 161–165; (f) Uskokovic, M. R.; Hen-
derson, T.; Reese, C.; Lee, H. L.; Grethe, G.; Gutzwiller,
J. J. Am. Chem. Soc. 1978, 100, 571–576; (g) Takano, S.;
Takahashi, M.; Hatakeyama, S.; Ogasawara, K. J. Chem.
Soc., Chem. Commun. 1979, 556–557; (h) Imanishi, T.;
Inoue, M.; Wada, Y.; Hanaoka, M. Chem. Pharm. Bull.
1982, 30, 1925–1928; (i) Funk, R. L.; Munger, J. D., Jr.
J. Org. Chem. 1984, 49, 4319–4322; (j) Yoo, S.-e.; Yi, K.
Y.; Lee, S.-H.; Jeong, N. Synlett 1990, 575–576.
13. (a) Sugai, T.; Mori, K. Synthesis 1988, 19–22; (b) Laumen,
K.; Schneider, M. P. J. Chem. Soc., Chem. Commun. 1986,
1298–1299.
14. Reviews: (a) Kobayashi, Y. Curr. Org. Chem. 2003, 7, 133–
147; (b) Kobayashi, Y. Trends Org. Chem. 1998, 7, 27–43.
15. (a) Ito, M.; Matsuumi, M.; Murugesh, M. G.; Kobayashi,
Y. J. Org. Chem. 2001, 66, 5881–5889; (b) Kobayashi, Y.;
Ito, M.; Igarashi, J. Tetrahedron Lett. 2002, 43, 4829–
4832; (c) Matsuumi, M.; Ito, M.; Kobayashi, Y. Synlett
2002, 1508–1510; (d) Kobayashi, Y.; Murugesh, M. G.;
Nakano, M.; Takahisa, E.; Usmani, S. B.; Ainai, T.
J. Org. Chem. 2002, 67, 7110–7123; (e) Ainai, T.; Ito, M.;
Kobayashi, Y. Tetrahedron Lett. 2003, 44, 3983–3986;
(f) Ainai, T.; Matsuumi, M.; Kobayashi, Y. J. Org.
Chem. 2003, 68, 7825–7832; (g) Ainai, T.; Wang, Y.-G.;
Tokoro, Y.; Kobayashi, Y. J. Org. Chem. 2003, 68, 7825–
7832.
16. Deardorff, D. R.; Linde, R. G., II; Martin, A. M.;
Shulman, M. J. J. Org. Chem. 1989, 54, 2759–2762.
17. Acharya, H. P.; Kobayashi, Y. Tetrahedron Lett. 2004, 45,
1199–1202.
18. Ozonolysis in MeOH proceeded with somewhat lower
product selectivity.
19. Grieco, P. A.; Gilman, S.; Nishizawa, M. J. Org. Chem.
1976, 41, 1485–1486.
20. A model reaction of I(CH2)5I with BzNH2 and NaH
successfully afforded the piperidine benzoyl amide in 64%
yield. However, reaction of 13 with BzNH2 under similar
conditions was unsuccessful.
I
I BzNH2
NBzNaH
DMF, 70 ˚C
64%
.
21. An attempted conversion of the N-benzoyl piperidine
alcohol i, prepared from 13 by the sequence shown below,
into selenide ii was unsuccessful in our hand.
13
1) PMBNH2
2) BzCl
3) t-BuOK, H2O
ArSeCN
i
ii
NBz
OH
TBDPSO
NBz
SeAr
TBDPSO
16
PBu3
.
22. Campbell, K. N.; Tipson, R. S.; Elderfield, R. C.;
Campbell, B. K.; Clapp, M. A.; Gensler, W. J.; Morrison,
D.; Moran, W. J. J. Org. Chem. 1946, 11, 803–811.
23. Unno, R.; Michishita, H.; Inagaki, H.; Suzuki, Y.; Baba,
Y.; Jomori, T.; Moku, M.; Nishikawa, T.; Isobe, M.
Bioorg. Med. Chem. 1997, 5, 903–919.
24. Characteristic 1
H NMR signals (300 MHz, CDCl3) for
epoxide 19 and its diastereomer synthesized through
oxidation with AD-mix-a are d 4.15 (d, J ¼ 1:8 Hz)
and 4.17 (d, J ¼ 1:8 Hz), respectively, for proton at
C(9).
3786 J. Igarashi et al. / Tetrahedron Letters 45 (2004) 3783–3786

More Related Content

What's hot

Catalytic Antibodies_JACS 1987 Powell et. al.
Catalytic Antibodies_JACS 1987 Powell et. al.Catalytic Antibodies_JACS 1987 Powell et. al.
Catalytic Antibodies_JACS 1987 Powell et. al.Michael Powell
 
Diel's-Alder and Gattermann Koch Reactions
Diel's-Alder and Gattermann Koch ReactionsDiel's-Alder and Gattermann Koch Reactions
Diel's-Alder and Gattermann Koch ReactionsPRUTHVIRAJ K
 
Brindlay 1983 JOrganometChem
Brindlay 1983 JOrganometChemBrindlay 1983 JOrganometChem
Brindlay 1983 JOrganometChemJalal Hawari
 
Named reactions in organic synthesis
Named reactions in organic synthesisNamed reactions in organic synthesis
Named reactions in organic synthesisPRUTHVIRAJ K
 
ASYMMETRIC ORGANOCATALYSIS
ASYMMETRIC ORGANOCATALYSISASYMMETRIC ORGANOCATALYSIS
ASYMMETRIC ORGANOCATALYSISBasudeb Mondal
 
Amine rich nitrogen doped carbon dots
Amine rich nitrogen doped carbon dotsAmine rich nitrogen doped carbon dots
Amine rich nitrogen doped carbon dotsVnhL5
 
Benzoin Condenstation Reaction
Benzoin Condenstation ReactionBenzoin Condenstation Reaction
Benzoin Condenstation ReactionPRUTHVIRAJ K
 
Organic inorganic hybrid cobalt phthalocyanine/polyaniline as efficient catal...
Organic inorganic hybrid cobalt phthalocyanine/polyaniline as efficient catal...Organic inorganic hybrid cobalt phthalocyanine/polyaniline as efficient catal...
Organic inorganic hybrid cobalt phthalocyanine/polyaniline as efficient catal...Pawan Kumar
 
Deciphering reaction mechanism with intermediate trapping
Deciphering reaction mechanism with intermediate trappingDeciphering reaction mechanism with intermediate trapping
Deciphering reaction mechanism with intermediate trappingDaniel Morton
 

What's hot (20)

Nucleic acids
Nucleic acidsNucleic acids
Nucleic acids
 
Lalit Kumar
Lalit KumarLalit Kumar
Lalit Kumar
 
Catalytic Antibodies_JACS 1987 Powell et. al.
Catalytic Antibodies_JACS 1987 Powell et. al.Catalytic Antibodies_JACS 1987 Powell et. al.
Catalytic Antibodies_JACS 1987 Powell et. al.
 
Diel's-Alder and Gattermann Koch Reactions
Diel's-Alder and Gattermann Koch ReactionsDiel's-Alder and Gattermann Koch Reactions
Diel's-Alder and Gattermann Koch Reactions
 
Organophosphorous compounds
Organophosphorous compoundsOrganophosphorous compounds
Organophosphorous compounds
 
org lett tbt
org lett tbtorg lett tbt
org lett tbt
 
Indole: Lecture -1 (Hetero-cyclic chemistry)
Indole: Lecture -1 (Hetero-cyclic chemistry) Indole: Lecture -1 (Hetero-cyclic chemistry)
Indole: Lecture -1 (Hetero-cyclic chemistry)
 
Heterocyclic compounds pyrazole
Heterocyclic compounds pyrazoleHeterocyclic compounds pyrazole
Heterocyclic compounds pyrazole
 
Brindlay 1983 JOrganometChem
Brindlay 1983 JOrganometChemBrindlay 1983 JOrganometChem
Brindlay 1983 JOrganometChem
 
CHAN LAM COUPLING
CHAN LAM COUPLING CHAN LAM COUPLING
CHAN LAM COUPLING
 
Named reactions in organic synthesis
Named reactions in organic synthesisNamed reactions in organic synthesis
Named reactions in organic synthesis
 
ASYMMETRIC ORGANOCATALYSIS
ASYMMETRIC ORGANOCATALYSISASYMMETRIC ORGANOCATALYSIS
ASYMMETRIC ORGANOCATALYSIS
 
Free Radical Chemistry
Free Radical ChemistryFree Radical Chemistry
Free Radical Chemistry
 
Tetrahedron paper
Tetrahedron paperTetrahedron paper
Tetrahedron paper
 
Amine rich nitrogen doped carbon dots
Amine rich nitrogen doped carbon dotsAmine rich nitrogen doped carbon dots
Amine rich nitrogen doped carbon dots
 
Benzoin Condenstation Reaction
Benzoin Condenstation ReactionBenzoin Condenstation Reaction
Benzoin Condenstation Reaction
 
Chemo
ChemoChemo
Chemo
 
Organic inorganic hybrid cobalt phthalocyanine/polyaniline as efficient catal...
Organic inorganic hybrid cobalt phthalocyanine/polyaniline as efficient catal...Organic inorganic hybrid cobalt phthalocyanine/polyaniline as efficient catal...
Organic inorganic hybrid cobalt phthalocyanine/polyaniline as efficient catal...
 
Deciphering reaction mechanism with intermediate trapping
Deciphering reaction mechanism with intermediate trappingDeciphering reaction mechanism with intermediate trapping
Deciphering reaction mechanism with intermediate trapping
 
articl 2
articl 2articl 2
articl 2
 

Viewers also liked

Les titrages acido basiques
Les titrages acido basiquesLes titrages acido basiques
Les titrages acido basiquesMaurice Maeck
 
A cloud technology based web portal
A cloud technology based web portalA cloud technology based web portal
A cloud technology based web portalSowmith Reddy
 
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugsClinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugsSazan Jamil Ali
 
Isomerism Power point
Isomerism Power pointIsomerism Power point
Isomerism Power pointsuresh gdvm
 
Drugs used in hypertension
Drugs used in hypertensionDrugs used in hypertension
Drugs used in hypertensionSara Memon
 
итоги конкурса учитель года 2017
итоги конкурса учитель года    2017итоги конкурса учитель года    2017
итоги конкурса учитель года 2017firsov-maks
 
Тотығу – тотықсыздану реакцияларына ортаның әсері
Тотығу – тотықсыздану реакцияларына ортаның әсеріТотығу – тотықсыздану реакцияларына ортаның әсері
Тотығу – тотықсыздану реакцияларына ортаның әсеріBilim All
 
kit de rúbricas para evaluar el desarrollo de competencias socioemocionales p...
kit de rúbricas para evaluar el desarrollo de competencias socioemocionales p...kit de rúbricas para evaluar el desarrollo de competencias socioemocionales p...
kit de rúbricas para evaluar el desarrollo de competencias socioemocionales p...Manuel Villanueva
 
Taller 10 practica innovador grupo 1 3
Taller 10 practica innovador   grupo 1  3Taller 10 practica innovador   grupo 1  3
Taller 10 practica innovador grupo 1 3Edwin Riascos
 
Resonancia y respuesta en frecuencia de circuitos rlc
Resonancia y respuesta en frecuencia de circuitos rlcResonancia y respuesta en frecuencia de circuitos rlc
Resonancia y respuesta en frecuencia de circuitos rlcLexandro Suarez Zambrano
 
Penuntun praktikum fisika dasar
Penuntun praktikum fisika dasarPenuntun praktikum fisika dasar
Penuntun praktikum fisika dasarHelvyEffendi
 

Viewers also liked (19)

Lesson 2 Isomerism
Lesson 2 IsomerismLesson 2 Isomerism
Lesson 2 Isomerism
 
Les titrages acido basiques
Les titrages acido basiquesLes titrages acido basiques
Les titrages acido basiques
 
A cloud technology based web portal
A cloud technology based web portalA cloud technology based web portal
A cloud technology based web portal
 
Assignment on isomerism
Assignment on isomerismAssignment on isomerism
Assignment on isomerism
 
Chapter 21
Chapter 21Chapter 21
Chapter 21
 
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugsClinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
 
Chiral drugs
Chiral drugsChiral drugs
Chiral drugs
 
Isomerism Power point
Isomerism Power pointIsomerism Power point
Isomerism Power point
 
Alkaloids ars
Alkaloids arsAlkaloids ars
Alkaloids ars
 
Drugs used in hypertension
Drugs used in hypertensionDrugs used in hypertension
Drugs used in hypertension
 
итоги конкурса учитель года 2017
итоги конкурса учитель года    2017итоги конкурса учитель года    2017
итоги конкурса учитель года 2017
 
Тотығу – тотықсыздану реакцияларына ортаның әсері
Тотығу – тотықсыздану реакцияларына ортаның әсеріТотығу – тотықсыздану реакцияларына ортаның әсері
Тотығу – тотықсыздану реакцияларына ортаның әсері
 
Coltan de Luisa Olmos 1004
Coltan de Luisa Olmos 1004 Coltan de Luisa Olmos 1004
Coltan de Luisa Olmos 1004
 
kit de rúbricas para evaluar el desarrollo de competencias socioemocionales p...
kit de rúbricas para evaluar el desarrollo de competencias socioemocionales p...kit de rúbricas para evaluar el desarrollo de competencias socioemocionales p...
kit de rúbricas para evaluar el desarrollo de competencias socioemocionales p...
 
Patanjali
PatanjaliPatanjali
Patanjali
 
Stereoisomerism(1)
Stereoisomerism(1)Stereoisomerism(1)
Stereoisomerism(1)
 
Taller 10 practica innovador grupo 1 3
Taller 10 practica innovador   grupo 1  3Taller 10 practica innovador   grupo 1  3
Taller 10 practica innovador grupo 1 3
 
Resonancia y respuesta en frecuencia de circuitos rlc
Resonancia y respuesta en frecuencia de circuitos rlcResonancia y respuesta en frecuencia de circuitos rlc
Resonancia y respuesta en frecuencia de circuitos rlc
 
Penuntun praktikum fisika dasar
Penuntun praktikum fisika dasarPenuntun praktikum fisika dasar
Penuntun praktikum fisika dasar
 

Similar to Tong hop quinin

Molecules 22-00357
Molecules 22-00357Molecules 22-00357
Molecules 22-00357elshimaa eid
 
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...Alexander Decker
 
Solution- and solid-phase synthesis of 4-hydroxy-4,5-dihydroisoxazole derivat...
Solution- and solid-phase synthesis of 4-hydroxy-4,5-dihydroisoxazole derivat...Solution- and solid-phase synthesis of 4-hydroxy-4,5-dihydroisoxazole derivat...
Solution- and solid-phase synthesis of 4-hydroxy-4,5-dihydroisoxazole derivat...Peter ten Holte
 
A convenient synthesis of some diarylurea and thiourea derivatives as antimic...
A convenient synthesis of some diarylurea and thiourea derivatives as antimic...A convenient synthesis of some diarylurea and thiourea derivatives as antimic...
A convenient synthesis of some diarylurea and thiourea derivatives as antimic...Alexander Decker
 
indole-200409095121.pptx
indole-200409095121.pptxindole-200409095121.pptx
indole-200409095121.pptxJaved Iqbal
 
Project_Ionic_Liquid_Master 1 of Chemistry and Biology
Project_Ionic_Liquid_Master 1 of Chemistry and BiologyProject_Ionic_Liquid_Master 1 of Chemistry and Biology
Project_Ionic_Liquid_Master 1 of Chemistry and BiologyJing YI
 
Methanol to Ethanol by Homologation - Kinetic Study
Methanol to Ethanol by Homologation - Kinetic StudyMethanol to Ethanol by Homologation - Kinetic Study
Methanol to Ethanol by Homologation - Kinetic StudyPatrick Françoisse
 
Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...
Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...
Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...Alexander Decker
 
JOC-Liu-1987
JOC-Liu-1987JOC-Liu-1987
JOC-Liu-1987Paul Liu
 
Synthesis, Characterization and Study of Antioxidant Activities of Some New P...
Synthesis, Characterization and Study of Antioxidant Activities of Some New P...Synthesis, Characterization and Study of Antioxidant Activities of Some New P...
Synthesis, Characterization and Study of Antioxidant Activities of Some New P...IJRES Journal
 
Organocatalytic enantioselective conjugate addition of aldehydes to maleimides
Organocatalytic enantioselective conjugate addition of aldehydes to maleimidesOrganocatalytic enantioselective conjugate addition of aldehydes to maleimides
Organocatalytic enantioselective conjugate addition of aldehydes to maleimidesDrMAdamSayah
 
PNAS-1998-Barawkar-11047-52
PNAS-1998-Barawkar-11047-52PNAS-1998-Barawkar-11047-52
PNAS-1998-Barawkar-11047-52Dinesh Barawkar
 

Similar to Tong hop quinin (20)

Molecules 22-00357
Molecules 22-00357Molecules 22-00357
Molecules 22-00357
 
Org Let PASS
Org Let PASSOrg Let PASS
Org Let PASS
 
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...
Heterogeneous solid liquid catalysis of n-glycosylation by natural phosphate ...
 
Solution- and solid-phase synthesis of 4-hydroxy-4,5-dihydroisoxazole derivat...
Solution- and solid-phase synthesis of 4-hydroxy-4,5-dihydroisoxazole derivat...Solution- and solid-phase synthesis of 4-hydroxy-4,5-dihydroisoxazole derivat...
Solution- and solid-phase synthesis of 4-hydroxy-4,5-dihydroisoxazole derivat...
 
A convenient synthesis of some diarylurea and thiourea derivatives as antimic...
A convenient synthesis of some diarylurea and thiourea derivatives as antimic...A convenient synthesis of some diarylurea and thiourea derivatives as antimic...
A convenient synthesis of some diarylurea and thiourea derivatives as antimic...
 
indole-200409095121.pptx
indole-200409095121.pptxindole-200409095121.pptx
indole-200409095121.pptx
 
Project_Ionic_Liquid_Master 1 of Chemistry and Biology
Project_Ionic_Liquid_Master 1 of Chemistry and BiologyProject_Ionic_Liquid_Master 1 of Chemistry and Biology
Project_Ionic_Liquid_Master 1 of Chemistry and Biology
 
Methanol to Ethanol by Homologation - Kinetic Study
Methanol to Ethanol by Homologation - Kinetic StudyMethanol to Ethanol by Homologation - Kinetic Study
Methanol to Ethanol by Homologation - Kinetic Study
 
Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...
Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...
Novel approach to synthesis of pentofurano nucleoside assisted natural phosph...
 
JOC '96 OH-Ester HPI
JOC '96 OH-Ester HPIJOC '96 OH-Ester HPI
JOC '96 OH-Ester HPI
 
JOC-Liu-1987
JOC-Liu-1987JOC-Liu-1987
JOC-Liu-1987
 
Methoxy porphyrins
Methoxy porphyrinsMethoxy porphyrins
Methoxy porphyrins
 
Ijaret 06 10_007
Ijaret 06 10_007Ijaret 06 10_007
Ijaret 06 10_007
 
SBrand_Paquette
SBrand_PaquetteSBrand_Paquette
SBrand_Paquette
 
Synthesis, Characterization and Study of Antioxidant Activities of Some New P...
Synthesis, Characterization and Study of Antioxidant Activities of Some New P...Synthesis, Characterization and Study of Antioxidant Activities of Some New P...
Synthesis, Characterization and Study of Antioxidant Activities of Some New P...
 
Synthesis of (-)-Deoxypukalide
Synthesis of (-)-DeoxypukalideSynthesis of (-)-Deoxypukalide
Synthesis of (-)-Deoxypukalide
 
Organocatalytic enantioselective conjugate addition of aldehydes to maleimides
Organocatalytic enantioselective conjugate addition of aldehydes to maleimidesOrganocatalytic enantioselective conjugate addition of aldehydes to maleimides
Organocatalytic enantioselective conjugate addition of aldehydes to maleimides
 
1
11
1
 
SBrand_VLA4
SBrand_VLA4SBrand_VLA4
SBrand_VLA4
 
PNAS-1998-Barawkar-11047-52
PNAS-1998-Barawkar-11047-52PNAS-1998-Barawkar-11047-52
PNAS-1998-Barawkar-11047-52
 

Recently uploaded

Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Silpa
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.Silpa
 
Genetics and epigenetics of ADHD and comorbid conditions
Genetics and epigenetics of ADHD and comorbid conditionsGenetics and epigenetics of ADHD and comorbid conditions
Genetics and epigenetics of ADHD and comorbid conditionsbassianu17
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusNazaninKarimi6
 
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxPSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxSuji236384
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .Poonam Aher Patil
 
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....muralinath2
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsSérgio Sacani
 
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsTransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsSérgio Sacani
 
POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.Silpa
 
300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptxryanrooker
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceAlex Henderson
 
Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Silpa
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...Scintica Instrumentation
 
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptxClimate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptxDiariAli
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptxSilpa
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Silpa
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY1301aanya
 
Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptxArvind Kumar
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxRenuJangid3
 

Recently uploaded (20)

Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
 
Genetics and epigenetics of ADHD and comorbid conditions
Genetics and epigenetics of ADHD and comorbid conditionsGenetics and epigenetics of ADHD and comorbid conditions
Genetics and epigenetics of ADHD and comorbid conditions
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxPSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .
 
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
 
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune WaterworldsBiogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
Biogenic Sulfur Gases as Biosignatures on Temperate Sub-Neptune Waterworlds
 
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRingsTransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
TransientOffsetin14CAftertheCarringtonEventRecordedbyPolarTreeRings
 
POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.
 
300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical Science
 
Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
 
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptxClimate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY
 
Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptx
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptx
 

Tong hop quinin

  • 1. Stereocontrolled synthesis of quinine and quinidine Junji Igarashi, Masahiro Katsukawa, Yong-Gang Wang, Hukum P. Acharya and Yuichi Kobayashi* Department of Biomolecular Engineering, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8501, Japan Received 12 February 2004; revised 10 March 2004; accepted 12 March 2004 Abstract—Disubstituted cyclopentene was prepared from cyclopentene monoacetate and transferred into disubstituted piperidine via oxidative cleavage of the olefin moiety followed by piperidine ring formation. The piperidine was then condensed at the side chain with a quinoline part to afford the olefin precursor of quinine. Finally, the olefin was converted into quinine through the corresponding epoxide. Quinidine was synthesized in a similar way. Ó 2004 Elsevier Ltd. All rights reserved. Quinine and quinidine have been used as effective ther- apeutic agents against malaria for over three centuries, and, recently, other medicinal applications have been reported for these alkaloids.1 On the other hand, the unique structure of these alkaloids has attracted much attention as chiral catalysts in asymmetric reactions.2 Usually structural modifications, when required, have been performed at the hydroxyl and/or amino group sites, providing moderate to high efficiencies in various reactions. In cases where efficiency is not high, modifi- cation of the structural backbone would be an alterna- tive way of attaining higher efficiency. To execute research work along this line, it is indispensable to establish a flexible approach to these alkaloids. N N OMe OH N N OMe OH quinine (1) quinidine (2) 8 9 3 4 The results of the previous investigation over 50 years into the synthesis of these alkaloids are suggestive of achieving successful total synthesis. These works are briefly described in the first and stereoselective total synthesis of quinine (1) published by Stork et al. in 2001,3 who prepared the 9-deoxy-quinine 3 in a stereo- selective way through a 2,4,5-trisubstituted piperidine (Fig. 1). Previously, Uskokovic and co-workers4 and Gates et al.5 independently synthesized the deoxy-qui- nine 3 and converted it into 1 by hydroxylation using O2 and t-BuOK with 5:1 stereoselectivity. This step was modified by Stork (O2, NaH, DMSO) to afford 1 more selectively (14:1). However, the synthesis seems hardly applicable to quinidine synthesis because the method developed is specialized for production of the key tri- substituted piperidine. Quite recently, Jacobsen and co-workers reported synthesis of 1 and 2.6 In his syn- thesis, the 3,4-disubstituted piperidine, synthesized with a 3:1 ratio regarding the cis/trans substitutions at C(3) and C(4), was transformed, after condensation with the quinoline part, into epoxide 4 (for 1) and the diaste- reomeric epoxide (for 2), respectively, through the Sharpless AD reaction, and each epoxide was converted 4 N N OMe 3 OMe NHN O 4 3 Figure 1. The previous intermediates for synthesis of quinine (1). Keywords: Quinine; Quinidine; Piperidine; Cyclopentene-1,3-diol monoacetate; Epoxide ring opening. * Corresponding author. Tel./fax: +81-45-924-5789; e-mail: ykobayas@ bio.titech.ac.jp 0040-4039/$ - see front matter Ó 2004 Elsevier Ltd. All rights reserved. doi:10.1016/j.tetlet.2004.03.085 Tetrahedron Letters 45 (2004) 3783–3786 Tetrahedron Letters
  • 2. into the target alkaloid. These epoxides were originally synthesized and cyclized to these alkaloids by Uskoko- vic and co-workers,4 though at that time the synthesis of the epoxide was nonstereoselective.7 Herein, we report stereoselective synthesis of a 3,4-disubstituted piperidine and its conversion into 1 and 2. We have chosen epoxide 4 as the key intermediate of 1, and envisioned a synthesis of 4 as illustrated in Scheme 1 from olefin 58 by using steps consisting of the Sharpless et al. asymmetric dihydroxylation9 and subsequent epoxide ring formation.10 On the other hand, we selected piperidine aldehyde 6 and quinoline phosphonate 7 as the parts of olefin 5. While a number of synthetic methods of the 3,4-disubstituted piperidines of this type (the acid is known as meroquinene) have been reported,11;12 we investigated an alternative route start- ing with acetate 813 because a variety of carbon nucleo- philes as substituents on the piperidine ring can be in- stalled on the cyclopentene ring by using reactions developed by us14;15 and others.16 The strategy based on these reactions is a synthetic advantage to execute the study mentioned above. On the other hand, the previous syntheses of the substituted piperidines seem to lack such flexibility. Synthesis of the piperidine aldehyde 6 through key cyclopentene 11 and its conversion into quinine (1) are presented in Scheme 2. Monoacetate 8 (95% ee) was converted into methyl ester 9. High yield of 98% for step a was attained by using the conditions recently developed by us.17 Reduction of the ester and selective protection of the primary hydroxyl group furnished 10 in 63% yield. Claisen rearrangement with vinyl ether and Hg(OAc)2 as a catalyst at 190 °C afforded aldehyde, which upon reduction with NaBH4 and subsequent 1 O 4 + AcO OH 6 (1R)-isomer 1 5 N OMe NBz OHC NBz N OMe P(OEt)2 7 8 Scheme 1. Retrosynthesis of quinine (1). Scheme 2. Synthesis of quinine (1): (a) CH2(CO2Me)2, t-BuOK, Pd(PPh3)4 (cat.); (b) KI, DMF, 125 °C; (c) LiAlH4; (d) TBDPSCl, imidazole; (e) CH2@CHOEt, Hg(OAc)2 (cat.), 190 °C; (f) NaBH4; (g) t-BuCOCl, Et3N, CH2Cl2; (h) O3, n-PrOH, )78 °C, then NaBH4; (i) I2, PPh3, imidazole; (j) BnNH2, dioxane; (k) ClCO2 Et, toluene; (l) NaOEt, EtOH; (m) o-(NO2)C6H4SeCN, PBu3, THF then 35% H2O2, THF; (n) MeLi, 0 °C; (o) BzCl; (p) TBAF; (q) PCC; (r) 7, NaH, THF, rt; (s) AD-mix-b, 0 °C to rt; (t) MeC(OMe)3, PPTS (cat.), CH2Cl2, TMSCl, K2CO3, MeOH; (u) DIBAL-H, toluene; (v) DMF, 160 °C. 3784 J. Igarashi et al. / Tetrahedron Letters 45 (2004) 3783–3786
  • 3. protection of the resulting hydroxyl group as the piva- loyl ester (Piv ¼ t-BuCO) produced the key cyclopen- tene 11 in good overall yield. With the necessary substituents for piperidine aldehyde 6 being installed as masked forms, construction of the piperidine ring was then studied. Ozonolysis of cyclo- pentene 11 in n-PrOH18 at )78 °C followed by reductive work-up with NaBH4 afforded alcohol 12, which was converted into iodide 13 in 72% yield from 11. Nucleo- philic amino cyclization of 13 with BnNH2 in dioxane at 100 °C produced the N-benzyl piperidine 14 quantita- tively. The N-protection was changed to the ethoxy- carbonyl group with ClCO2Et to produce the piperidine carbamate 15 in good yield. Transformation of 15 with EtONa in refluxing EtOH furnished the alcohol, which was converted into olefin 16 by the Grieco et al. pro- tocol.19 The overall yield of 16 from 13 was 75%. The N-protective group (CO2Et) of 16 was altered to the benzoyl group at this stage to produce the benzoyl amine 17 in 61% yield.20;21 Finally, the TBDPS group was removed with TBAF, and the resulting alcohol was oxidized with PCC to the key aldehyde 6 in good yield. Phosphonate 7 was synthesized from commercially available 20 (Scheme 3). At the outset, 20 was converted into quinoline 21 by the literature procedure.22 The methyl group on the ring was then oxidatively trans- formed into the hydroxymethyl group according to the method of Unno et al. and Isobe.23 Remaining conver- sion was accomplished under the conditions presented in Scheme 3, furnishing the key quinoline 7 in 50% yield from alcohol 22. Condensation of the key piperidine 6 with anion derived from the quinoline 7 and NaH produced olefin 5 in 82% yield (Scheme 2). Dihydroxylation of 5 with AD-mix-b proceeded as usual and the resulting diol 18 was con- verted into epoxide 1924 in 85% yield (two steps) by using the protocol developed by Sharpless and co-workers.10 Finally, the N-benzoyl group was removed and the resulting 4 underwent cyclization with the nitrogen atom in hot DMF to furnish quinine (1) in 66% yield from 19. Quinine thus synthesized was iden- tical with that obtained from Sigma by 1 H NMR spec- troscopy and TLC analysis. In a similar manner, olefin 5 was converted into the corresponding diol 24 with AD-mix-a, and the same transformation as described above furnished quinidine (2) in good yield (Scheme 4). Acknowledgements This work was supported by a Grant-in-Aid for Scien- tific Research from the Ministry of Education, Science, Sports, and Culture, Japan. References and notes 1. (a) White, N. J.; Looareesuwan, S.; Warrell, D. A.; Warrell, M. J.; Bunnag, D.; Harinasuta, T. Am. J. Med. 1982, 73, 564–572; (b) List, A. F. Leukemia 1996, 10, 937– 942; (c) Wilairatana, P.; Krudsood, S.; Treeprasertsuk, S.; Chalermrut, K.; Looareesuwan, S. Arch. Med. Res. 2002, 33, 416–421. 2. Recent and selected reports: (a) Wynberg, H.; Staring, E. G. J. J. Am. Chem. Soc. 1982, 104, 166–168; (b) Jacobsen, E. N.; Marko, I.; Mungall, W. S.; Schroeder, G.; Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 1968– 1970; (c) Amberg, W.; Bennani, Y. L.; Chadha, R. K.; Crispino, G. A.; Davis, W. D.; Hartung, J.; Jeong, K.-S.; Ogino, Y.; Shibata, T.; Sharpless, K. B. J. Org. Chem. 1993, 58, 844–849; (d) Becker, H.; Sharpless, K. B. Angew. Chem., Int. Ed. Engl. 1996, 35, 448–451; (e) Li, G.; Angert, H. H.; Sharpless, K. B. Angew. Chem., Int. Ed. Engl. 1996, 35, 2813–2817; (f) Lygo, B.; Wainwright, P. G. Tetrahe- dron Lett. 1997, 38, 8595–8598; (g) Lygo, B.; Wainwright, P. G. Tetrahedron Lett. 1998, 39, 1599–1602; (h) Iwabuchi, Y.; Nakatani, M.; Yokoyama, N.; Hatakeyama, S. J. Am. Chem. Soc. 1999, 121, 10219–10220; (i) Blake, A. J.; Friend, C. L.; Outram, R. J.; Simpkins, N. S.; Whitehead, A. J. Tetrahedron Lett. 2001, 42, 2877–2881; (j) Jew, S.-s.; Yoo, M.-S.; Jeong, B.-S.; Park, Y., II; Park, H.-g. Org. Lett. 2002, 4, 4245–4248; (k) Lambers, M.; Beijer, F. H.; Padron, J. M.; Toth, I.; deVries, J. G. J. Org. Chem. 2002, 67, 5022–5024; (l) Rogers, L. M.-A.; Rouden, J.; Lecomte, L.; Lasne, M.-C. Tetrahedron Lett. 2003, 44, 3047–3050; (m) Jew, S.-s.; Jeong, B.-S.; Lee, J.-H.; Yoo, M.-S.; Lee, Scheme 3. Synthesis of quinoline phosphonate 7: (a) H2SO4; (b) POCl3; (c) Zn, AcOH; (d) m-CPBA, CH2Cl2, rt; (e) Ac2O, rt; (f) K2CO3, MeOH; (g) SOCl2, CH2Cl2, reflux; (h) H–P(@O)(OEt)2, n-BuLi, THF. 5 N OMe NBz OH OH 2 a b 87% N OMe NBz c,d 88% O 55% 24 25 Scheme 4. Synthesis of quinidine (2): (a) AD-mix-a, 0 °C to rt; (b) MeC(OMe)3, PPTS (cat.), CH2Cl2, TMSCl, K2CO3, MeOH; (c) DI- BAL-H, toluene; (d) DMF, 160 °C. J. Igarashi et al. / Tetrahedron Letters 45 (2004) 3783–3786 3785
  • 4. Y.-J.; Park, B.-s.; Kim, M. G.; Park, H.-g. J. Org. Chem. 2003, 68, 4514–4516, and references cited therein. 3. Stork, G.; Niu, D.; Fujimoto, R. A.; Koft, E. R.; Balkovec, J. M.; Tata, J. R.; Dake, G. R. J. Am. Chem. Soc. 2001, 123, 3239–3242. 4. (a) Gutzwiller, J.; Uskokovic, M. J. Am. Chem. Soc. 1970, 92, 204–205; (b) Gutzwiller, J.; Uskokovic, M. R. J. Am. Chem. Soc. 1978, 100, 576–581. 5. Gates, M.; Sugavanam, B.; Schreiber, W. L. J. Am. Chem. Soc. 1970, 92, 205–207. 6. Raheem, I. T.; Goodman, S. N.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 706–707. 7. Similar quinuclidine formations from epoxides have been reported: (a) Grethe, G.; Gutzwiller, J.; Lee, H. L.; Uskokovic, M. R. Helv. Chim. Acta 1972, 55, 1044–1047; (b) Gutzwiller, J.; Uskokovic, M. R. Helv. Chim. Acta 1973, 56, 1494–1503; (c) Taylor, E. C.; Martin, S. F. J. Am. Chem. Soc. 1972, 94, 6218–6220; (d) Lygo, B.; Crosby, J.; Lowdon, T.; Wainwright, P. G. Tetrahedron 1999, 55, 2795–2810. 8. Olefin 5 has been reported to afford a mixture of 9-deoxy-quinine 3 and the C(8)-epimer in 1:1 ratio: (a) see Refs. 4a,5,7c; (b) Taylor, E. C.; Martin, S. F. J. Am. Chem. Soc. 1974, 96, 8095–8102. 9. (a) Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.; Morikawa, K.; Wang, Z.-M.; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768–2771; (b) Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483–2547. 10. Kolb, H.; Sharpless, K. B. Tetrahedron 1992, 48, 10515– 10530. 11. (a) Brown, R. T.; Leonard, J. J. Chem. Soc., Chem. Commun. 1978, 725–726; (b) Hanessian, S.; Faucher, A.-M.; Leger, S. Tetrahedron 1990, 46, 231–243; (c) Danieli, B.; Lesma, G.; Mauro, M.; Palmisano, G.; Passarella, D. Tetrahedron: Asymmetry 1990, 1, 793–800; (d) Barco, A.; Benetti, S.; De Risi, C.; Pollini, G. P.; Romagnoli, R.; Spalluto, G.; Zanirato, V. Tetrahedron 1994, 50, 2583–2590. 12. (a) Woodward, R. B.; Doering, W. E. J. Am. Chem. Soc. 1945, 67, 860–874; (b) Uskokovic, M.; Reese, C.; Lee, H. L.; Grethe, G.; Gutzwiller, J. J. Am. Chem. Soc. 1971, 93, 5902–5904; (c) Uskokovic, M.; Gutzwiller, J.; Henderson, T. J. Am. Chem. Soc. 1970, 92, 203–204; (d) Grethe, G.; Lee, H. L.; Mitt, T.; Uskokovic, M. R. Helv. Chim. Acta 1973, 56, 1485–1494; (e) Augustine, R.; Koletar, G. Synth. Commun. 1974, 4, 161–165; (f) Uskokovic, M. R.; Hen- derson, T.; Reese, C.; Lee, H. L.; Grethe, G.; Gutzwiller, J. J. Am. Chem. Soc. 1978, 100, 571–576; (g) Takano, S.; Takahashi, M.; Hatakeyama, S.; Ogasawara, K. J. Chem. Soc., Chem. Commun. 1979, 556–557; (h) Imanishi, T.; Inoue, M.; Wada, Y.; Hanaoka, M. Chem. Pharm. Bull. 1982, 30, 1925–1928; (i) Funk, R. L.; Munger, J. D., Jr. J. Org. Chem. 1984, 49, 4319–4322; (j) Yoo, S.-e.; Yi, K. Y.; Lee, S.-H.; Jeong, N. Synlett 1990, 575–576. 13. (a) Sugai, T.; Mori, K. Synthesis 1988, 19–22; (b) Laumen, K.; Schneider, M. P. J. Chem. Soc., Chem. Commun. 1986, 1298–1299. 14. Reviews: (a) Kobayashi, Y. Curr. Org. Chem. 2003, 7, 133– 147; (b) Kobayashi, Y. Trends Org. Chem. 1998, 7, 27–43. 15. (a) Ito, M.; Matsuumi, M.; Murugesh, M. G.; Kobayashi, Y. J. Org. Chem. 2001, 66, 5881–5889; (b) Kobayashi, Y.; Ito, M.; Igarashi, J. Tetrahedron Lett. 2002, 43, 4829– 4832; (c) Matsuumi, M.; Ito, M.; Kobayashi, Y. Synlett 2002, 1508–1510; (d) Kobayashi, Y.; Murugesh, M. G.; Nakano, M.; Takahisa, E.; Usmani, S. B.; Ainai, T. J. Org. Chem. 2002, 67, 7110–7123; (e) Ainai, T.; Ito, M.; Kobayashi, Y. Tetrahedron Lett. 2003, 44, 3983–3986; (f) Ainai, T.; Matsuumi, M.; Kobayashi, Y. J. Org. Chem. 2003, 68, 7825–7832; (g) Ainai, T.; Wang, Y.-G.; Tokoro, Y.; Kobayashi, Y. J. Org. Chem. 2003, 68, 7825– 7832. 16. Deardorff, D. R.; Linde, R. G., II; Martin, A. M.; Shulman, M. J. J. Org. Chem. 1989, 54, 2759–2762. 17. Acharya, H. P.; Kobayashi, Y. Tetrahedron Lett. 2004, 45, 1199–1202. 18. Ozonolysis in MeOH proceeded with somewhat lower product selectivity. 19. Grieco, P. A.; Gilman, S.; Nishizawa, M. J. Org. Chem. 1976, 41, 1485–1486. 20. A model reaction of I(CH2)5I with BzNH2 and NaH successfully afforded the piperidine benzoyl amide in 64% yield. However, reaction of 13 with BzNH2 under similar conditions was unsuccessful. I I BzNH2 NBzNaH DMF, 70 ˚C 64% . 21. An attempted conversion of the N-benzoyl piperidine alcohol i, prepared from 13 by the sequence shown below, into selenide ii was unsuccessful in our hand. 13 1) PMBNH2 2) BzCl 3) t-BuOK, H2O ArSeCN i ii NBz OH TBDPSO NBz SeAr TBDPSO 16 PBu3 . 22. Campbell, K. N.; Tipson, R. S.; Elderfield, R. C.; Campbell, B. K.; Clapp, M. A.; Gensler, W. J.; Morrison, D.; Moran, W. J. J. Org. Chem. 1946, 11, 803–811. 23. Unno, R.; Michishita, H.; Inagaki, H.; Suzuki, Y.; Baba, Y.; Jomori, T.; Moku, M.; Nishikawa, T.; Isobe, M. Bioorg. Med. Chem. 1997, 5, 903–919. 24. Characteristic 1 H NMR signals (300 MHz, CDCl3) for epoxide 19 and its diastereomer synthesized through oxidation with AD-mix-a are d 4.15 (d, J ¼ 1:8 Hz) and 4.17 (d, J ¼ 1:8 Hz), respectively, for proton at C(9). 3786 J. Igarashi et al. / Tetrahedron Letters 45 (2004) 3783–3786